Clinical Trial Update: A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

This is a Phase I dual-dose escalation trial assessing radiation therapy with Nab-paclitaxel for locally advanced unresectable and borderline resectable pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer Borderline Resectable
• Pancreatic Cancer Locally Advanced

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy, Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy | Phase 1 | Status: ACTIVE_NOT_RECRUITING